NHS approves Enhertu for HER2-low breast cancer in England

Thousands of women in England with HER2-low advanced breast cancer will get access to the life-extending drug Enhertu on the NHS after ministers reached a pricing deal. The treatment, which can give patients an extra seven months on average, had initially been rejected on cost grounds. Enhertu has been available in Scotland for more than two years.

3-source coverage 3 references

GuardianSkyBBC

Life-extending drug for breast cancer patients now on NHS

In brief

What the sources add

A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed.

Source coverage

Media reports

Guardian 3h ago

Women in England with incurable breast cancer to get life-extending drug on NHS

Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful. About 1,000 women a year with HER2-low advanced breast cancer will be able to obtain Enhertu from Thursday after ministers and the drug’s makers…

Sky 4h ago

Life-extending drug for breast cancer patients now on NHS

A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed.

BBC 8h ago

New hope for breast cancer patients as life-extending drug now on NHS in England

Discovery

See what’s emerging. See what’s changing.

Explore stories gaining momentum and continuing events with new developments.

Explore Discovery